Trump Announces Historic Tariffs, Sparking Concerns of a Trade War

The Trump administration has initiated mass layoffs impacting 10,000 staff across major U.S. health agencies, including the FDA, CDC, and NIH, aiming to reduce federal spending. According to multiple sources, these layoffs began on April 1, 2025, with security personnel restricting access to certain employees shortly after they received dismissal notices.
Health Secretary Robert F. Kennedy Jr. described the cuts as necessary for streamlining an overstaffed bureaucracy. However, the elimination of key personnel, including scientists responsible for public health, cancer research, and vaccine approval processes, has raised alarms regarding the country's capability to manage health crises, particularly an ongoing measles outbreak and emergent bird flu cases.
Notably, Peter Stein, head of the FDA’s Office of New Drugs, resigned rather than face termination, reflecting the turmoil within the agency that is critical for drug regulation. Former FDA Commissioner Robert Califf remarked on LinkedIn that the organization, rich in institutional knowledge, is now significantly compromised. The downsizing, which affected multiple departments, has led to long lines and confusion as employees attempted to access their workplaces post-layoff.